Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| plasmacytoid dendritic cell | 12 studies | 28% ± 10% | |
| plasma cell | 5 studies | 23% ± 9% | |
| epithelial cell | 5 studies | 28% ± 11% | |
| fibroblast | 4 studies | 20% ± 4% | |
| type B pancreatic cell | 3 studies | 37% ± 18% | |
| ciliated cell | 3 studies | 24% ± 2% | |
| dendritic cell | 3 studies | 28% ± 10% |
Insufficient scRNA-seq data for expression of ALG2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 1420.05 | 459 / 459 | 100% | 51.92 | 1118 / 1118 |
| esophagus | 100% | 1303.27 | 1445 / 1445 | 100% | 37.41 | 183 / 183 |
| intestine | 100% | 1482.61 | 966 / 966 | 100% | 46.17 | 527 / 527 |
| liver | 100% | 2174.00 | 226 / 226 | 100% | 36.63 | 406 / 406 |
| lung | 100% | 2057.77 | 578 / 578 | 100% | 41.89 | 1155 / 1155 |
| ovary | 100% | 2035.97 | 180 / 180 | 100% | 39.83 | 430 / 430 |
| pancreas | 100% | 2708.41 | 328 / 328 | 100% | 41.80 | 178 / 178 |
| prostate | 100% | 2060.43 | 245 / 245 | 100% | 75.02 | 502 / 502 |
| stomach | 100% | 1560.81 | 359 / 359 | 100% | 42.61 | 286 / 286 |
| skin | 100% | 1805.85 | 1808 / 1809 | 100% | 34.98 | 472 / 472 |
| kidney | 100% | 1577.12 | 89 / 89 | 100% | 43.87 | 900 / 901 |
| bladder | 100% | 1450.52 | 21 / 21 | 100% | 38.01 | 503 / 504 |
| adrenal gland | 100% | 3270.31 | 258 / 258 | 100% | 52.02 | 229 / 230 |
| uterus | 100% | 1707.71 | 170 / 170 | 100% | 37.20 | 457 / 459 |
| thymus | 100% | 1896.15 | 653 / 653 | 100% | 52.42 | 602 / 605 |
| brain | 99% | 947.71 | 2604 / 2642 | 100% | 29.42 | 705 / 705 |
| adipose | 100% | 1470.41 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 34.06 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 45.40 | 29 / 29 |
| spleen | 100% | 1785.56 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 32.88 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 25.79 | 1 / 1 |
| blood vessel | 99% | 1101.35 | 1328 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 99% | 928.42 | 795 / 803 | 0% | 0 | 0 / 0 |
| heart | 98% | 941.26 | 845 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 74% | 971.81 | 684 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006490 | Biological process | oligosaccharide-lipid intermediate biosynthetic process |
| GO_0006487 | Biological process | protein N-linked glycosylation |
| GO_0006488 | Biological process | dolichol-linked oligosaccharide biosynthetic process |
| GO_0006486 | Biological process | protein glycosylation |
| GO_0098554 | Cellular component | cytoplasmic side of endoplasmic reticulum membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0102704 | Molecular function | GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity |
| GO_0000033 | Molecular function | alpha-1,3-mannosyltransferase activity |
| GO_0004378 | Molecular function | GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | ALG2 |
| Protein name | Alpha-1,3/1,6-mannosyltransferase ALG2 (EC 2.4.1.132) (EC 2.4.1.257) (Asparagine-linked glycosylation protein 2 homolog) (GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase) (GDP-Man:Man(1)GlcNAc(2)-PP-dolichol mannosyltransferase) (GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase) ALG2 alpha-1,3/1,6-mannosyltransferase |
| Synonyms | UNQ666/PRO1298 |
| Description | FUNCTION: Mannosylates Man(2)GlcNAc(2)-dolichol diphosphate and Man(1)GlcNAc(2)-dolichol diphosphate to form Man(3)GlcNAc(2)-dolichol diphosphate. . |
| Accessions | A0A0A0MTE0 ENST00000238477.5 ENST00000476832.2 [Q9H553-1] Q9H553 ENST00000319033.7 [Q9H553-2] |